Article in the Philanthropy Network Journal
We are happy to share with you an article (in French only) which appeared in the 1st Philanthropy Network Journal. Click here to read the article in full.
European Society of Pharmacogenomics and Personalised Therapy – Summer School
CANSEARCH co organised, from 25 - 27 September, a Summer School with the European Society of Pharmacogenomics and Personalized Therapy (ESPT) and the Swiss Personalized Health Network (SPHN) at the Geneva Biotech Campus on Personalized Medicine. More than 30 experts presented the latest developments in this innovative field. http://www.esptsummerschool.eu
Book on childhood and adolescent cancer co-autored by Prof. Ansari
The new book co-authored by Prof Marc Ansari "Childhood and adolescent cancer" at Editions Planète Santé is out!
American Hematology Society (ASH)
We are pleased to announce the participation of Professor Ansari and his researchers at the 59th ASH Congress to be held from 9-12 December 2017 in Atlanta. Presentations will focus on: Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? a Multicenter EBMT-PDWP Study. Outcome [...]
Pediatric palliative care: situation in Switzerland
On 28 November Prof Ansari will participate in an interdisciplinary research symposium to discuss paediatric palliative care in Switzerland.
Conférence ESPT
Prof. Ansari sera présent à l'occasion de la 4ème conférence sur pharmacogenomics et la médecine personnalisée.
International Day of Child Cancer
On the occasion of the International Day of Child Cancer (15 February), the RTS broadcast an interview with Dr Fabienne GUMY PAUSE, pediatric haematologist-oncologist at HUG and researcher in the CANSEARCH laboratory, Long-term treatments and the creation of a follow-up program within the HUGs for young people cured of cancer.
European Horizon 2020 Grant
CANSEARCH officially received the European Horizon 2020 grant in order to open the SIOPEL liver tumor research program in Switzerland (Hepatoblastoma, Hepatocarcinoma, clinical study CHILTERN-PHITT trial, SPOG as a national sponsor). Geneva is also the national IP of this study which is excellent for the management of oncological liver diseases in Switzerland.
American Society of Hematology (ASH)
Professeur Ansari had the honour to be invited to present his research on Busulfan in the context of acute lymphoblastic leukaemia. This is an immense privilege because the American Society of Hematology is recognised as a leading player in blood disease research. www.hematology.org see article
Health Conference, Lausanne
Planète Santé Live, took place in Lausanne at the end of November. This was a meeting of Swiss health leaders, bringing together more than 450 personalities from the world of health, research, politics and economics. Among other things, it aims to provide insight into recent advances in cancer research. Professor Marc Ansari was invited to [...]